About
Technology
Issues
FAQ
Links
Official Page
How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.